TrialLeukemia2012
A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma.
J R Berenson et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled ittrialcites it